Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2021-05-21 4:32 pm Sale | 13D | SPRUCE BIOSCIENCES INC SPRB | Novo Holdings A/S | 4,514,336 19.4% | -475,000 (-9.52%) | View |
2021-05-03 4:46 pm Sale | 13G | PRAXIS PRECISION MEDICINES INC PRAX | Novo Holdings A/S | 1,442,080 3.7% | -1,000,000 (-40.95%) | View |
2021-04-14 4:45 pm Purchase | 13G | VectivBio Holding AG VECT | Novo Holdings A/S | 3,522,019 10.3% | 3,522,019 (New Position) | View |
2021-04-14 4:43 pm Purchase | 13D | Reneo Pharmaceuticals Inc. RPHM | Novo Holdings A/S | 3,430,377 14.2% | 3,430,377 (New Position) | View |
2021-03-31 4:33 pm Purchase | 13D | LAVA THERAPEUTICS N V SHS LVTX | Novo Holdings A/S | 3,327,312 13.1% | 3,327,312 (New Position) | View |
2021-03-31 4:31 pm Purchase | 13D | Edgewise Therapeutics Inc. EWTX | Novo Holdings A/S | 5,587,207 11.4% | 5,587,207 (New Position) | View |
2021-03-30 4:55 pm Sale | 13D | INOZYME PHARMA INC INZY | Novo Holdings A/S | 1,969,379 8.4% | -225,000 (-10.25%) | View |
2021-03-11 4:14 pm Unchanged | 13D | MORPHIC HLDG INC MORF | Novo Holdings A/S | 2,645,446 7.4% | 0 (Unchanged) | View |
2021-02-17 4:30 pm Unchanged | 13G | Inogen Inc INGN | Novo Holdings A/S | 3,549,320 16.1% | 0 (Unchanged) | View |
2021-02-11 4:36 pm Purchase | 13D | Bolt Biotherapeutics Inc. BOLT | Novo Holdings A/S | 4,503,991 13% | 4,503,991 (New Position) | View |
2021-02-08 5:02 pm Purchase | 13G | PRAXIS PRECISION MEDICINES INC PRAX | Novo Holdings A/S | 2,442,080 6.4% | 2,442,080 (New Position) | View |
2021-02-08 5:01 pm Sale | 13G | Harmony Biosciences Holdings Inc. HRMY | Novo Holdings A/S | 3,622,471 6.4% | -132,502 (-3.53%) | View |
2021-02-08 4:58 pm Sale | 13G | Galera Therapeutics Inc. GRTX | Novo Holdings A/S | 2,959,021 11.9% | -450,000 (-13.20%) | View |
2021-02-05 4:38 pm Sale | 13G | Verona Pharma plc VRNA | Novo Holdings A/S | 12,893,250 3.1% | -9,746,417 (-43.05%) | View |
2021-02-01 4:31 pm Sale | 13D | INOZYME PHARMA INC INZY | Novo Holdings A/S | 2,194,379 9.4% | -375,000 (-14.59%) | View |
2020-12-30 1:36 pm Sale | 13G | SeaSpine Holdings Corp SPNE | Novo Holdings A/S | 1,346,487 4.8% | -311,550 (-18.79%) | View |
2020-12-18 4:31 pm Unchanged | 13D | Mirum Pharmaceuticals Inc. MIRM | Novo Holdings A/S | 2,445,147 8.4% | 0 (Unchanged) | View |
2020-11-05 4:38 pm Purchase | 13D | GALECTO INC GLTO | Novo Holdings A/S | 2,497,791 10.2% | 2,497,791 (New Position) | View |
2020-10-22 4:31 pm Purchase | 13D | ALIGOS THERAPEUTICS INC ALGS | Novo Holdings A/S | 2,614,563 7.7% | 2,614,563 (New Position) | View |
2020-10-16 4:48 pm Purchase | 13D | SPRUCE BIOSCIENCES INC SPRB | Novo Holdings A/S | 4,989,336 21.5% | 4,989,336 (New Position) | View |